Amyloid in 25% of 70-year-olds
About 25% of community-dwelling people in their seventies have amyloid in their brains without any symptoms of dementia.
Snapshot · The Peter Attia Drive
#399 ‒ The evolution of Alzheimer's disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.
Explore episode
Jul 13, 2026
Where this was said
Blood-based biomarkers and asymptomatic screening
At 43:07 · chapter starts 40:15
Blood-based Alzheimer's biomarkers are improving rapidly, but Gayatri Devi cautions strongly against over-reliance on them. She opens with a case study: a patient diagnosed with Alzheimer's by a respected neurologist based solely on an abnormal Quest AD Detect test, who turned out to have a negative amyloid PET scan. The fundamental problem is that these blood tests are validated against amyloid PET scans — but amyloid is present in roughly 25% of asymptomatic 70-year-olds, 30%+ of 80-year-olds, and 44% of 90-year-olds without dementia [1] — Gayatri Devi "Blood-based Alzheimer's biomarkers are validated against amyloid PET scans — but 25–44% of people over 70 have amyloid in their brains with…" 42:13 . The Alzheimer's Association and the International Working Group hold opposing positions on this: the former diagnoses Alzheimer's based on amyloid alone; the latter requires amyloid plus tau plus clinical symptoms. Gayatri Devi sides closer to the International Working Group, reserving preclinical testing for high-risk individuals with strong family history and genetic risk factors, and warns that indiscriminate testing creates a large population of 'patients in waiting' who may never develop disease.
The Blood Biomarker Trap in Alzheimer's Diagnosis
Blood-based Alzheimer's biomarkers are validated against amyloid PET scans — but 25–44% of people over 70 have amyloid in their brains without any dementia. Diagnosing Alzheimer's from a blood test alone risks creating a massive population of 'patients in waiting' who may never develop disease.
Amyloid in 44% of 90-year-olds
By age 90, approximately 44% of community-dwelling people have brain amyloid without dementia symptoms, undermining blood-test specificity.
Similar snapshots
More than 3 in 4 Americans report anxiety or depression
Mental health challenges are nearly universal — BetterHelp's own research found the majority of Americans experiencing symptoms right now.
Medicaid 5-year look-back rule
When applying for Medicaid to cover nursing home costs, there is a 5-year look-back period that can disqualify applicants who gave away or spent down assets.
Pipe broke → hydrogen sulfide studio air
A broken pipe filled the Bad Friends studio with what the hosts identified as hydrogen sulfide — microscopic fecal aeroparticles — that the crew denied smelling.
Robot surgery: 10x less blood loss
Fei-Fei Li's father's liver surgery performed by a da Vinci robot resulted in 10 times less blood loss than a typical open liver surgery, thanks to laparoscopic precision.
115M US adults have prediabetes
Approximately 115 million adults in the US currently have prediabetes, most of whom are unaware, according to the Lingo sponsor segment.
Drug overdose deaths: 110K to 80K to 70K
Drug overdose deaths in the US fell from 110,000 to 80,000 in 2024, and then to roughly 70,000 — the largest single-year drop the CDC has ever recorded.
Men's overdose rate fell 27% in one year
Men's overdose death rate fell 27% in a single year, outpacing the 23% drop for women.
Ages 15–24 overdose deaths down 37%
The steepest decline in overdose deaths was among 15–24-year-olds, whose rate fell 37%.
Nurses walk miles per shift fetching items
Fei-Fei Li observed that on a given hospital shift, nurses walk miles just to fetch medicine and supplies, illustrating a clear use case for assistive robotics in healthcare.
